Drug Trial Radar · NCT01603407
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Last checked: Nov 19, 2026Latest source record: Aug 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
196
Actual
Start
Jan 2013
Primary completion
Nov 2019
Study completion Nov 2019
Sponsor
- Lead sponsor
- University of RochesterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Newcastle University; University Medical Center Freiburg; National Institute of Neurological Disorders and Stroke (NINDS)
- First posted
- May 23, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 4 years, up to 7 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR DMD) study will compare three ways of giving corticosteroids to boys with Duchenne muscular dystrophy (DMD) to determine which of the three ways increases muscle strength the most, and which causes the fewest side effects. Using the results of this study, the investigators aim to provide patients and families with clearer information about the best way to take these drugs.
Conditions
- Duchenne Muscular Dystrophy
Interventions
PrednisoneDrug
daily prednisone (0.75 mg/kg/day) tablets for 36-60 months
PrednisoneDrug
intermittent prednisone (0.75 mg/kg/day, 10 days on, 10 days off) tablets for 36 to 60 months
DeflazacortDrug
daily deflazacort (0.9 mg/kg/day) tablets for 36-60 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Forced Vital CapacityTime frame: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
- Rise From the Floor VelocityTime frame: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
- Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction With Treatment ScoreTime frame: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
Locations
32 sites in 5 countries. Site status is shown where the registry gives one.
University of California Los Angeles (UCLA) Medical Center
Los Angeles, California
University of California Davis Medical Center
Sacramento, California
Children's National Medical Center
Washington D.C., District of Columbia
Nemours Children's Hospital
Orlando, Florida
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Boston Children's Hospital
Boston, Massachusetts
University of New Mexico Health Science Center
Albuquerque, New Mexico
University of Rochester Medical Center
Rochester, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Nationwide Children's Hospital
Columbus, Ohio
Penn State Hershey Medical Center
Hershey, Pennsylvania
Vanderbilt Children's Hospital
Nashville, Tennessee
University of Utah Medical Center
Salt Lake City, Utah
Alberta Children's Hospital
Calgary, Alberta, Canada
Children's Hospital London Health Sciences Centre
London, Ontario, Canada
Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario, Canada
Children's Hospital, Technical University Dresden
Dresden, Germany
University Hospital of Essen
Essen, Germany
University Medical Center Freiburg
Freiburg im Breisgau, Germany
Children's University Hospital, Göttingen
Göttingen, Germany
University of Messina AOU Policlinico Gaetano Martino
Messina, Italy
C. Besta Neurological Institute Foundation
Milan, Italy
University of Padova School of Medicine
Padova, Italy
Neuromuscular Center University of Turin
Torino, Italy
Heart of England NHS Foundation Trust Birmingham Heartland's Hospital
Birmingham, United Kingdom
Alder Hey Children's Hospital NHS Trust
Liverpool, United Kingdom
Great Ormond Street Hospital for Children NHS Trust
London, United Kingdom
Royal Manchester Children's Hospital
Manchester, United Kingdom
Institute of Human Genetics, International Centre for Life
Newcastle upon Tyne, United Kingdom
The General Infirmary at Leeds
Leeds, England, United Kingdom
Greater Glasgow and Clyde NHS Yorkhill Hospital
Glasgow, Scotland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.